169 related articles for article (PubMed ID: 19019415)
1. Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.
Metcalfe KA; Fan I; McLaughlin J; Risch HA; Rosen B; Murphy J; Bradley L; Armel S; Sun P; Narod SA
Gynecol Oncol; 2009 Jan; 112(1):68-72. PubMed ID: 19019415
[TBL] [Abstract][Full Text] [Related]
2. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
[TBL] [Abstract][Full Text] [Related]
3. Preventing ovarian cancer through genetic testing: a population-based study.
Finch A; Bacopulos S; Rosen B; Fan I; Bradley L; Risch H; McLaughlin JR; Lerner-Ellis J; Narod SA
Clin Genet; 2014 Nov; 86(5):496-9. PubMed ID: 24199689
[TBL] [Abstract][Full Text] [Related]
4. Uptake of testing for germline
Stearnes G; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Cohen PA
Int J Gynecol Cancer; 2019 Jul; 29(6):1038-1042. PubMed ID: 31101686
[TBL] [Abstract][Full Text] [Related]
5. Real-world health services utilisation and outcomes after
Dossa F; Cusimano MC; Sutradhar R; Metcalfe K; Little T; Lerner-Ellis J; Eisen A; Meschino WS; Baxter NN
BMJ Open; 2018 Sep; 8(9):e025317. PubMed ID: 30181190
[TBL] [Abstract][Full Text] [Related]
6. Building the What Comes Next Cohort for
Dossa F; Metcalfe K; Sutradhar R; Little T; Eisen A; Chun K; Meschino WS; Velsher L; Ellis JL; Baxter NN
CMAJ Open; 2021; 9(3):E874-E885. PubMed ID: 34870614
[TBL] [Abstract][Full Text] [Related]
7. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
8. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA
Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R
Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991
[TBL] [Abstract][Full Text] [Related]
11. Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study.
Daniels MS; Babb SA; King RH; Urbauer DL; Batte BA; Brandt AC; Amos CI; Buchanan AH; Mutch DG; Lu KH
J Clin Oncol; 2014 Apr; 32(12):1249-55. PubMed ID: 24638001
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients.
Hasmad HN; Lai KN; Wen WX; Park DJ; Nguyen-Dumont T; Kang PCE; Thirthagiri E; Ma'som M; Lim BK; Southey M; Woo YL; Teo SH
Gynecol Oncol; 2016 May; 141(2):318-322. PubMed ID: 26541979
[TBL] [Abstract][Full Text] [Related]
13. Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.
Shipman H; Flynn S; MacDonald-Smith CF; Brenton J; Crawford R; Tischkowitz M; ; Hulbert-Williams NJ
J Genet Couns; 2017 Dec; 26(6):1280-1291. PubMed ID: 28540621
[TBL] [Abstract][Full Text] [Related]
14. Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.
Evans DG; Shenton A; Woodward E; Lalloo F; Howell A; Maher ER
BMC Cancer; 2008 May; 8():155. PubMed ID: 18513387
[TBL] [Abstract][Full Text] [Related]
15. Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.
McLaughlin JR; Rosen B; Moody J; Pal T; Fan I; Shaw PA; Risch HA; Sellers TA; Sun P; Narod SA
J Natl Cancer Inst; 2013 Jan; 105(2):141-8. PubMed ID: 23257159
[TBL] [Abstract][Full Text] [Related]
16. Clinical management of women with genomic BRCA1 and BRCA2 mutations.
Chang J; Elledge RM
Breast Cancer Res Treat; 2001 Sep; 69(2):101-13. PubMed ID: 11759816
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
RodrÃguez AO; Llacuachaqui M; Pardo GG; Royer R; Larson G; Weitzel JN; Narod SA
Gynecol Oncol; 2012 Feb; 124(2):236-43. PubMed ID: 22044689
[TBL] [Abstract][Full Text] [Related]
18. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families.
Claes K; Poppe B; Coene I; Paepe AD; Messiaen L
Br J Cancer; 2004 Mar; 90(6):1244-51. PubMed ID: 15026808
[TBL] [Abstract][Full Text] [Related]
20. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
